SCHEMBL7307785

SCHEMBL7307785

C1=CC2=CC=C1C2.O=C(O)CCS(=O)(=O)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.54
MMP7 P09237 2/20 0.54
MMP14 P50281 2/20 0.54
HTT P42858 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
KDM4E B2RXH2 1/20 0.48
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
MMP13 P45452 3/20 0.46
MMP9 P14780 2/20 0.46
MMP1 P03956 2/20 0.46
ALDH1A1 P00352 1/20 0.46
MMP3 P08254 1/20 0.46
HSD11B1 P28845 1/20 0.45
MMP8 P22894 1/20 0.44
ADAMTS4 O75173 1/20 0.44
MMP12 P39900 2/20 0.43
GAA P10253 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
APEX1 P27695 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7010023 0.88 MMP2 (0.68) MMP2MMP7MMP14HTTNPSR1
SCHEMBL7302796 0.87 MMP1 (0.59) MMP2MMP7MMP14HDAC1HDAC2
SCHEMBL7297071 0.84 HSD11B1 (0.51) HTTNPSR1KDM4EALDH1A1HSD11B1
SCHEMBL1001018 0.78 HSD11B1 (0.69) HTTNPSR1KDM4EHDAC1HDAC2
Hydrochloric Acid SCHEMBL10584023 0.76 HSD11B1 (0.67) HTTNPSR1KDM4EHDAC1HDAC2
SCHEMBL7010857 0.75 HSD11B1 (0.58) MMP2MMP7MMP14HTTNPSR1
SCHEMBL27466099 0.75 MMP2 (0.59) MMP2MMP7MMP14HDAC1HDAC2
SCHEMBL7014945 0.74 HTT (0.55) MMP2MMP7MMP14HTTNPSR1
SCHEMBL7077673 0.72 HTT (0.50) MMP2MMP7MMP14HTTNPSR1
SCHEMBL7075505 0.72 HSD11B1 (0.62) MMP2MMP7MMP14HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed